Unity Health And Rehabilitation Center | |
1404 Nw 22nd Street, Miami, Florida 33142 | |
(305) 325-1050 | |
Name | Unity Health And Rehabilitation Center |
---|---|
Location | 1404 Nw 22nd Street, Miami, Florida |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 294 |
Occupancy Rate | 82.35% |
Medicare ID (CCN) | 105510 |
Legal Business Name | Jackson Heights Nh, L.l.c. |
Ownership Type | For Profit - Corporation |
NPI Number | 1184629743 |
Organization Name | JACKSON HEIGHTS NH, L.L.C. |
Doing Business As | UNITY HEALTH AND REHABILITATION CENTER |
Address | 1404 Nw 22nd St, Miami, FL 33142 |
Phone Number | 305-325-1050 |
News Archive
Helen Genova, PhD, research scientist at Kessler Foundation, received a Women of Excellence Award in Health Sciences from the Union County Commission on the Status of Women. In the Foundation's Neuropsychology and Neuroscience Laboratory, she investigates the effects of multiple sclerosis (MS) and traumatic brain injury on cognitive function with grant funding.
Eight weeks after receiving their first samples of Zika virus, scientists at the University of Massachusetts Medical School have shown that a very small protein we all have in our bodies, interferon-induced protein 3 (IFITM3), can dramatically reduce the ability of Zika virus to infect human and mouse cells.
Endo Pharmaceuticals announced today that its partners, Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc. have received a Paragraph IV Certification Notice from Watson Laboratories, Inc. advising of the filing of an Abbreviated New Drug Application (ANDA) for a generic version of LIDODERM® (lidocaine topical patch 5%).
AltheaDx, Inc. today announced the formation of a strategic partnership with Compendia Bioscience to combine their respective core capabilities in assay development, validation and bioinformatics. The two companies will jointly create novel products and services focused on cancer biomarker discovery and subsequent development of tests that predict patient outcomes in clinical trials.
"These new guidelines were formulated by a group of leading experts in child psychiatry and are the most up-to-date and comprehensive set of guidelines for the treatment of children and adolescents with bipolar disorder," said Dr. Kowatch. "They represent a major step towards practicing evidence-based medicine in this difficult to treat group of patients.
› Verified 5 days ago
NPI Number | 1538817044 |
Organization Name | JACKSON HEIGHTS NURSING AND REHAB LLC |
Address | 1404 Nw 22nd St, Miami, FL 33142 |
Phone Number | 305-325-1050 |
News Archive
Helen Genova, PhD, research scientist at Kessler Foundation, received a Women of Excellence Award in Health Sciences from the Union County Commission on the Status of Women. In the Foundation's Neuropsychology and Neuroscience Laboratory, she investigates the effects of multiple sclerosis (MS) and traumatic brain injury on cognitive function with grant funding.
Eight weeks after receiving their first samples of Zika virus, scientists at the University of Massachusetts Medical School have shown that a very small protein we all have in our bodies, interferon-induced protein 3 (IFITM3), can dramatically reduce the ability of Zika virus to infect human and mouse cells.
Endo Pharmaceuticals announced today that its partners, Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc. have received a Paragraph IV Certification Notice from Watson Laboratories, Inc. advising of the filing of an Abbreviated New Drug Application (ANDA) for a generic version of LIDODERM® (lidocaine topical patch 5%).
AltheaDx, Inc. today announced the formation of a strategic partnership with Compendia Bioscience to combine their respective core capabilities in assay development, validation and bioinformatics. The two companies will jointly create novel products and services focused on cancer biomarker discovery and subsequent development of tests that predict patient outcomes in clinical trials.
"These new guidelines were formulated by a group of leading experts in child psychiatry and are the most up-to-date and comprehensive set of guidelines for the treatment of children and adolescents with bipolar disorder," said Dr. Kowatch. "They represent a major step towards practicing evidence-based medicine in this difficult to treat group of patients.
› Verified 5 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Helen Genova, PhD, research scientist at Kessler Foundation, received a Women of Excellence Award in Health Sciences from the Union County Commission on the Status of Women. In the Foundation's Neuropsychology and Neuroscience Laboratory, she investigates the effects of multiple sclerosis (MS) and traumatic brain injury on cognitive function with grant funding.
Eight weeks after receiving their first samples of Zika virus, scientists at the University of Massachusetts Medical School have shown that a very small protein we all have in our bodies, interferon-induced protein 3 (IFITM3), can dramatically reduce the ability of Zika virus to infect human and mouse cells.
Endo Pharmaceuticals announced today that its partners, Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc. have received a Paragraph IV Certification Notice from Watson Laboratories, Inc. advising of the filing of an Abbreviated New Drug Application (ANDA) for a generic version of LIDODERM® (lidocaine topical patch 5%).
AltheaDx, Inc. today announced the formation of a strategic partnership with Compendia Bioscience to combine their respective core capabilities in assay development, validation and bioinformatics. The two companies will jointly create novel products and services focused on cancer biomarker discovery and subsequent development of tests that predict patient outcomes in clinical trials.
"These new guidelines were formulated by a group of leading experts in child psychiatry and are the most up-to-date and comprehensive set of guidelines for the treatment of children and adolescents with bipolar disorder," said Dr. Kowatch. "They represent a major step towards practicing evidence-based medicine in this difficult to treat group of patients.
› Verified 5 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $34184 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 19.81 | 14.46 |
Percentage of long-stay residents who lose too much weight | 5.77 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 72.62 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.48 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0.35 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 0.91 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 84.66 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 28.94 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 30.14 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 2.68 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 26.68 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 18.73 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 6.9 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 81.64 | 95.98 |
Percentage of short-stay residents who made improvements in function | 59.89 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 39.47 | 82.93 |
News Archive
Helen Genova, PhD, research scientist at Kessler Foundation, received a Women of Excellence Award in Health Sciences from the Union County Commission on the Status of Women. In the Foundation's Neuropsychology and Neuroscience Laboratory, she investigates the effects of multiple sclerosis (MS) and traumatic brain injury on cognitive function with grant funding.
Eight weeks after receiving their first samples of Zika virus, scientists at the University of Massachusetts Medical School have shown that a very small protein we all have in our bodies, interferon-induced protein 3 (IFITM3), can dramatically reduce the ability of Zika virus to infect human and mouse cells.
Endo Pharmaceuticals announced today that its partners, Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc. have received a Paragraph IV Certification Notice from Watson Laboratories, Inc. advising of the filing of an Abbreviated New Drug Application (ANDA) for a generic version of LIDODERM® (lidocaine topical patch 5%).
AltheaDx, Inc. today announced the formation of a strategic partnership with Compendia Bioscience to combine their respective core capabilities in assay development, validation and bioinformatics. The two companies will jointly create novel products and services focused on cancer biomarker discovery and subsequent development of tests that predict patient outcomes in clinical trials.
"These new guidelines were formulated by a group of leading experts in child psychiatry and are the most up-to-date and comprehensive set of guidelines for the treatment of children and adolescents with bipolar disorder," said Dr. Kowatch. "They represent a major step towards practicing evidence-based medicine in this difficult to treat group of patients.
› Verified 5 days ago
Coral Gables Nursing And Rehabilitation Center Location: 7060 Sw 8th Street, Miami, Florida 33144 Phone: (305) 261-1363 | |
Miami Jewish Health Systems, Inc Location: 5200 Ne 2nd Avenue, Miami, Florida 33137 Phone: (305) 751-8626 | |
Jackson Memorial Long Term Care Center Location: 2500 Nw 22nd Ave, Miami, Florida 33142 Phone: (786) 466-3000 | |
Miami Shores Nursing And Rehab Center Location: 9380 Nw 7th Avenue, Miami, Florida 33150 Phone: (305) 759-8711 |